Changzhou Humon Pharmaceutical

Changzhou Humon Pharmaceutical is a specialized pharmaceutical company based in Changzhou, China, focusing on the development, production, and sales of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. The company primarily serves the global market with a portfolio centered on treatments for chronic diseases, particularly in the cardiovascular and metabolic therapeutic areas. Their core expertise lies in the synthesis of statins and dipeptidyl peptidase 4 (DPP-4) inhibitors. Operating under strict GMP guidelines, Changzhou Humon provides both catalog products and custom manufacturing services to pharmaceutical companies worldwide. The firm is recognized for its technical proficiency in complex organic synthesis and its commitment to high-quality standards in chemical production. Through its manufacturing capabilities, it supports the supply chain for numerous generic and innovative drug products globally.